BRT offers tumor and specialized disease models to support customized studies evaluating therapeutic efficacy, immune responses, and disease-related outcomes.
BRT offers syngeneic tumor models to support customized studies evaluating therapeutic efficacy and immune response.
BRT offers specialized inflammatory and disease models to support customized studies evaluating immune response, therapeutic efficacy, and disease-related outcomes.
Tumor and specialized disease studies can be integrated with ex vivo and bioanalytical assessments to further characterize immune responses and treatment-related effects.
We work with clients to develop customized tumor and specialized disease studies based on specific research objectives, test articles, models, and study endpoints.
